PhRMA: Health Outcomes Research Program; PhRMA: Translational Medicine Program

Sponsor Deadline: 

Feb 1, 2021


PhRMA Foundation

UI Contact: 

PhRMA: Health Outcomes Research Program
deadline Feb. 1, 2021 
The PhRMA Health Outcomes Research program offers predoctoral and postdoctoral fellowships and research starter grants. Health Outcomes Research spans a broad spectrum of issues, from studies evaluating the effectiveness of a particular pharmaceutical intervention to the impact of reimbursement policies on the outcomes of care. It also ranges from the development and use of patient-level real-world data and tools to perform patient-based assessments to analyses of the best way to disseminate the results of outcomes research to providers or consumers to encourage behavior change.
Health Outcomes Research incorporates a variety of research methods, data and tools from different disciplines. The application of Health Outcomes Research principles in evaluating the design, delivery, safe use, and effectiveness of pharmaceuticals includes the following general areas: 

  • Pharmacoeconomics
  • Clinical Outcomes Assessment (COA)
  • Patient-Level Real-World Data and Analytic Tools

PhRMA: Translational Medicine Program
Deadline Feb. 1, 2021

The PhRMA Translational Medicine program offers post-doctoral fellowships and research starter grants. The goal of the program is to promote the development of an integrative approach towards clinical needs in diagnosis, treatment and prevention using both experimental and computational methods.
Translational medicine is a discipline focused on bridging discoveries in experimental and computational research to their application in clinical practice. Translational Medicine awards advance training and support career development of scientists engaged in research that significantly addresses specific clinician-defined problems and integrates innovative technologies with advanced biological, chemical, and pharmacological sciences and engineering methodologies. Emphasis will be placed on the identification of unmet clinical needs and the development of new experimental and computational approaches and technologies that facilitate the translation of research data into an elucidation and understanding of human biological and disease processes to directly support their solution.
Genetics (Molecular, Pharmacogenetics, Population, Medical)
•Genomics (Function, Structural, Toxicogenomics, Pharmacogenomics, Comparative)
•Systems (Biology and Pharmacology)
•Pathways and Networks
•Integrative Biology
•Modeling and Simulation
•Target Identification and Validation
•Biomarker Discovery and Validation
•Vaccine Development
•Molecular Epidemiology
•Disease Modeling